AVCR.V · Avricore Health Inc

-

Please sign in to comment on AVCR.V

1 Comment

Admin

4 years, 1 month ago

Avricore Health Inc is currently in a long term downtrend where the price is trading 1.2% below its 200 day moving average.

From a valuation standpoint, the stock is 60.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 402.7.

Avricore Health Inc's total revenue sank by 50.2% to $8K since the same quarter in the previous year.

Its net income has increased by 69.7% to $-207K since the same quarter in the previous year.

Finally, its free cash flow grew by 41.4% to $-180K since the same quarter in the previous year.

Based on the above factors, Avricore Health Inc gets an overall score of 3/5.

Exchange	V
CurrencyCode	CAD
ISIN	CA0545211090
Sector	Healthcare
Industry	Diagnostics & Research

Target Price	None
Market Cap	5M
PE Ratio	0.0
Beta	-1.61
Dividend Yield	None

ABOUT

Avricore Health Inc

Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

AVCR.V · Avricore Health Inc

-

Avricore Health Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Avricore Health Inc using a moving average strategy